Loading...

enVVeno Medical Corporation

NVNOWNASDAQ
Healthcare
Medical - Devices
$0.006
$-0.00(-32.98%)

enVVeno Medical Corporation (NVNOW) Stock Overview

Explore enVVeno Medical Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.1/100

Key Financials

Market Cap74M
P/E Ratio-3.83
EPS (TTM)$-1.90
ROE-0.51%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.01

NVNOW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of enVVeno Medical Corporation (NVNOW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.83 and a market capitalization of 74M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
0.00%
Profit Growth
$-1.05
7.22%
EPS Growth
$-1.05
33.51%
Operating Margin
-2866.63%
5.59%
ROE
-51.32%
7.22%
Dividend Yield
0.00%
Analyst Recommendations data is not available for NVNOWAnalyst Recommendations details for NVNOW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

CEO

Robert A. Berman

Employees

30

Headquarters

70 Doppler, Irvine, CA

Founded

2018

Frequently Asked Questions

;